Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL3064645 | 1.00 | MEN1 (0.42) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL2699241 | 0.94 | MEN1 (0.39) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL3259429 | 0.94 | MEN1 (0.39) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL28605265 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL14956549 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL15228033 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL1517835 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL27559148 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL14956194 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 | |
| Sulfuric Acid SCHEMBL20219 | 0.94 | MEN1 (0.46) | MEN1ALDH1A1TSHRKMT2ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3238699-B1 | COSMETIC COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE AND ANIONIC WATER-SOLUBLE POLYMER | AJINOMOTO KK (JP) | 2020-03-25 | — | — | EP | disclosed |
| CN-108697595-A | Interior silica containing microcapsule resin particle, its production method and application thereof | 积水化成品工业株式会社 | 2018-10-23 | — | — | CN | disclosed |
| EP-3238699-A1 | COSMETIC COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE AND ANIONIC WATER-SOLUBLE POLYMER | AJINOMOTO CO., INC. (JP) | 2017-11-01 | — | — | EP | disclosed |
| US-20170281496-A1 | COSMETIC COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE AND ANIONIC WATER-SOLUBLE POLYMER | AJINOMOTO CO., INC. (JP) | 2017-10-05 | — | — | US | disclosed |
| US-9539212-B2 | Vaccination composition | CRISTAL DELIVERY B.V. (NL) | 2017-01-10 | — | — | US | disclosed |
| US-20160030348-A1 | VACCINATION COMPOSITION | CRISTAL DELIVERY B.V. (NL) | 2016-02-04 | — | — | US | disclosed |
| US-5700946-A | ONE STEP CATALYTIC DEHYDROGENATION PROCESS OF N-(1-ALKOXYALKYL) COMPOUND | NIPPON SHOKUBAI CO., LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170281496-A1 | COSMETIC COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE AND ANIONIC WATER-SOLUBLE POLYMER | ASS1, ASNS, AADAT | MEN1 524/4885ALDH1A1 1092/4885TSHR 2740/4885 |
| US-20160030348-A1 | VACCINATION COMPOSITION | CD14, CD47, TLR5 | MEN1 2058/4885ALDH1A1 4774/4885TSHR 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.